BWXT insider filing: 300 shares shown after DER accrual for deferred RSUs
Rhea-AI Filing Summary
John M. Richardson, a director of BWX Technologies, Inc. (BWXT), filed a Form 4 disclosing a transaction dated 09/05/2025. The filing reports the acquisition of dividend equivalent rights (DERs) that accrued on four restricted stock unit (RSU) grants for which the reporting person elected to defer receipt of the underlying shares. Each RSU and each DER is described in the filing as a contingent right to receive one share of BWXT common stock. The reported transaction shows a price of $0 and indicates 300 shares beneficially owned following the transaction (ownership listed as direct). The Form 4 is signed on behalf of Mr. Richardson by an attorney-in-fact on 09/08/2025.
Positive
- Timely and complete disclosure of the transaction by the director, meeting Section 16 reporting requirements
- Clear explanation that the dividend equivalent rights relate to four deferred RSU grants and will be delivered proportionately with the RSUs
Negative
- None.
Insights
TL;DR: Routine insider disclosure of accrued dividend equivalent rights tied to deferred RSUs; no cash purchase or sale reported.
The Form 4 is a standard Section 16 disclosure showing that a director elected to defer RSU share receipt and received dividend equivalent rights associated with those RSUs. The transaction is recorded with a $0 price, consistent with non-cash, contingent awards rather than an open-market trade. The filing identifies 300 shares beneficially owned following the transaction and is executed by an attorney-in-fact, which is typical for administrative filings. From a compliance perspective, the report fulfills Section 16 reporting requirements without indicating an unusual transfer, sale, or related-party transaction.
TL;DR: Director deferred RSU receipts and recorded DERs; disclosure appears routine and aligned with equity compensation practices.
The explanation clarifies that DERs will be delivered proportionately with the underlying RSUs, indicating these rights are tied to existing equity awards rather than new grant activity. The filing names the reporting person as a director and shows direct ownership post-transaction, which provides transparency on potential insider holdings. There is no indication of acceleration, sale, or other governance actions in this filing.